Study of Hesperidin Therapy on COVID-19 Symptoms (HESPERIDIN)

Inclusion Criteria

• •Covid-19 positive by polymerase chain reaction (PCR) testing;
• •Participant must be able to evaluate their symptoms and report them in the symptoms diary;
• •Patients must be able to take their oral temperature daily with an electronic thermometer provided to them with study materials;
• •Males and females, at least 18 years of age, capable and willing to provide informed consent;
• •Female patient is either not of childbearing potential, defined as postmenopausal for at least 1 year or surgically sterile, or is of childbearing potential and practicing at least one method of contraception and preferably two complementary forms of contraception including a barrier method (e.g. male or female condoms, spermicides, sponges, foams, jellies, diaphragm, intrauterine device (IUD)) throughout the study;
• •Patient must have received a diagnosis of COVID-19 infection within the last 48 hours and have one or more symptoms;
• •Outpatient setting (not currently hospitalized or under immediate consideration for hospitalization);
• •Patient must be able and willing to comply with the requirements of this study protocol.